Why the study?
The authors sought to provide an overview of the progress and current directions of travel in antiplatelet therapy for ACS and PCI.
Answers are grounded in this paper and cite their sources.
Provides an overview of the progress and current directions in antiplatelet therapy for ACS and PCI, highlighting the shift towards personalized treatment.
inhibitor therapy. Herein, we provide an overview of the progress in the field of antiplatelet therapy for ACS and PCI over the years, showing the current directions of travel. Ongoing studies focusing on personalized antiplatelet treatment will hopefully yield further insight into ways of optimizing outcomes for the individual.
No takes yet. Share an insight, caveat, or question.
Gorog et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: